Open AccessEvaluating the Sensitivity of Sporadic Pancreatic Cancer to Poly(ADPribose) Polymerase (PARP) Inhibition (Velaparib, Olaparib, AG14361) as Single Agents and as Chemo-sensitizers
Author(s) -
Joseph Angel De Soto
Publication year - 2020
Language(s) - English
DOI - 10.47363/jcrr/2020(2)119
Subject(s) - gemcitabine , veliparib , parp inhibitor , olaparib , cisplatin , pancreatic cancer , poly adp ribose polymerase , medicine , cancer research , cancer , oncology , pharmacology , chemotherapy , chemistry , polymerase , enzyme , biochemistry